ArticleTheranostics2021
Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancer.
Qian Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it
ArticleTheranostics2021
Qian Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.